Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Slavin

Showing results (81-90 of 436) with videos related to

Pageof 44
Sort By:
Applied Biochemistry and Biotechnology|October 1, 1986
Depletion of human lymphocytes from peripheral blood and bone marrow by affinity ligands conjugated to agarose-polyacrolein microsphere beadsL Weiss, S Margel, S Slavin
Academic Medicine : Journal of the Association of American Medical Colleges|May 1, 1996
Addressing telephone medicine in the medical school curriculumR Usatine, M Wilkes, S Slavin
Cytokines, Cellular & Molecular Therapy|January 21, 2000
Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartmentsL Weiss, S Reich, S Slavin
Bone Marrow Transplantation|March 1, 1990
The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrowM Mumcuoglu, E Naparstek, S Slavin
Annals of the New York Academy of Sciences|February 3, 1999
Induction of bilateral transplantation tolerance to cellular and perfused allografts and xenografts with donor hematopoietic cellsS Slavin, O Gurevitch, T Prighozina
Leukemia Research|February 1, 1996
ASTA-Z 7557 impairs human natural killer (NK) cell activityR Condiotti, S Slavin, A Nagler
Leukemia Research|November 1, 1993
Minimal residual disease in murine B-cell leukemia (BCL1) detected by PCRT Pugatsch, L Weiss, S Slavin
Blood|March 15, 1994
Potential use of interleukin-6 in bone marrow transplantation: effects of recombinant human interleukin-6 after syngeneic and semiallogeneic bone marrow transplantation in miceT Givon, M Revel, S Slavin
Bone Marrow Transplantation|June 1, 1992
The role of recombinant cytokines and other immunomodulators on engraftment following allogeneic bone marrow transplantation in miceA Bieder, L Weiss, S Slavin
Transplantation Proceedings|April 21, 2007
Deletion of donor-reactive cells as a new conditioning regimen for allogeneic bone marrow transplantationT B Prigozhina, G Elkin, S Slavin
Pageof 44

Showing results (81-90 of 436) with videos related to

Sort By:
Pageof 44
Applied Biochemistry and Biotechnology|October 1, 1986
Depletion of human lymphocytes from peripheral blood and bone marrow by affinity ligands conjugated to agarose-polyacrolein microsphere beadsL Weiss, S Margel, S Slavin
Academic Medicine : Journal of the Association of American Medical Colleges|May 1, 1996
Addressing telephone medicine in the medical school curriculumR Usatine, M Wilkes, S Slavin
Cytokines, Cellular & Molecular Therapy|January 21, 2000
Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartmentsL Weiss, S Reich, S Slavin
Bone Marrow Transplantation|March 1, 1990
The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrowM Mumcuoglu, E Naparstek, S Slavin
Annals of the New York Academy of Sciences|February 3, 1999
Induction of bilateral transplantation tolerance to cellular and perfused allografts and xenografts with donor hematopoietic cellsS Slavin, O Gurevitch, T Prighozina
Leukemia Research|February 1, 1996
ASTA-Z 7557 impairs human natural killer (NK) cell activityR Condiotti, S Slavin, A Nagler
Leukemia Research|November 1, 1993
Minimal residual disease in murine B-cell leukemia (BCL1) detected by PCRT Pugatsch, L Weiss, S Slavin
Blood|March 15, 1994
Potential use of interleukin-6 in bone marrow transplantation: effects of recombinant human interleukin-6 after syngeneic and semiallogeneic bone marrow transplantation in miceT Givon, M Revel, S Slavin
Bone Marrow Transplantation|June 1, 1992
The role of recombinant cytokines and other immunomodulators on engraftment following allogeneic bone marrow transplantation in miceA Bieder, L Weiss, S Slavin
Transplantation Proceedings|April 21, 2007
Deletion of donor-reactive cells as a new conditioning regimen for allogeneic bone marrow transplantationT B Prigozhina, G Elkin, S Slavin
Pageof 44